je.st
news
Circassia Plans $285 Million London IPO for Allergy Vaccines
2014-02-06 20:30:04| Biotech - Topix.net
Circassia Holdings Ltd., a U.K. biotechnology company developing allergy vaccines, plans to raise about 175 million pounds in an initial public offering on the London Stock Exchange.
Tags: million
plans
london
ipo
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||